GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Gross Profit

NetraMark Holdings (XCNQ:AIAI) Gross Profit : C$0.22 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Gross Profit?

NetraMark Holdings's gross profit for the three months ended in Mar. 2024 was C$0.22 Mil. NetraMark Holdings's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.22 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. NetraMark Holdings's gross profit for the three months ended in Mar. 2024 was C$0.22 Mil. NetraMark Holdings's Revenue for the three months ended in Mar. 2024 was C$0.22 Mil. Therefore, NetraMark Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was N/A%.

NetraMark Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


NetraMark Holdings Gross Profit Historical Data

The historical data trend for NetraMark Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Gross Profit Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Gross Profit
- - 0.11 0.09

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.09 - - 0.22

Competitive Comparison of NetraMark Holdings's Gross Profit

For the Health Information Services subindustry, NetraMark Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetraMark Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's Gross Profit falls into.



NetraMark Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

NetraMark Holdings's Gross Profit for the fiscal year that ended in Sep. 2023 is calculated as

Gross Profit (A: Sep. 2023 )=Revenue - Cost of Goods Sold
=0.089 - 0
=0.09

NetraMark Holdings's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=0.222 - 0
=0.22

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.22 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

NetraMark Holdings's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.22 / 0.222
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


NetraMark Holdings  (XCNQ:AIAI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

NetraMark Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


NetraMark Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


NetraMark Holdings (XCNQ:AIAI) Business Description

Traded in Other Exchanges
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.
Executives
Andrew Parks Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines